Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

3,608 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
The significance of Elf-1 expression in epithelial ovarian carcinoma.
Takai N, Miyazaki T, Nishida M, Nasu K, Miyakawa I. Takai N, et al. Among authors: miyazaki t. Int J Mol Med. 2003 Sep;12(3):349-54. Int J Mol Med. 2003. PMID: 12883651
Clinical relevance of Elf-1 overexpression in endometrial carcinoma.
Takai N, Miyazaki T, Nishida M, Shang S, Nasu K, Miyakawa I. Takai N, et al. Among authors: miyazaki t. Gynecol Oncol. 2003 Jun;89(3):408-13. doi: 10.1016/s0090-8258(03)00131-8. Gynecol Oncol. 2003. PMID: 12798703
CaMKIV expression is associated with clinical stage and PCNA-labeling index in endometrial carcinoma.
Shang S, Takai N, Nishida M, Miyazaki T, Nasu K, Miyakawa I. Shang S, et al. Among authors: miyazaki t. Int J Mol Med. 2003 Feb;11(2):181-6. Int J Mol Med. 2003. PMID: 12525874
Expression of survivin is associated with malignant potential in epithelial ovarian carcinoma.
Takai N, Miyazaki T, Nishida M, Nasu K, Miyakawa I. Takai N, et al. Among authors: miyazaki t. Int J Mol Med. 2002 Aug;10(2):211-6. Int J Mol Med. 2002. PMID: 12119561
Ca(2+)/calmodulin-dependent protein kinase IV expression in epithelial ovarian cancer.
Takai N, Miyazaki T, Nishida M, Nasu K, Miyakawa I. Takai N, et al. Among authors: miyazaki t. Cancer Lett. 2002 Sep 26;183(2):185-93. doi: 10.1016/s0304-3835(02)00107-6. Cancer Lett. 2002. PMID: 12065094
Survivin expression correlates with clinical stage, histological grade, invasive behavior and survival rate in endometrial carcinoma.
Takai N, Miyazaki T, Nishida M, Nasu K, Miyakawa I. Takai N, et al. Among authors: miyazaki t. Cancer Lett. 2002 Oct 8;184(1):105-16. doi: 10.1016/s0304-3835(02)00190-8. Cancer Lett. 2002. PMID: 12104054 Retracted.
Nitrotyrosine in esophageal squamous cell carcinoma and relevance to p53 expression.
Kato H, Miyazaki T, Yoshikawa M, Nakajima M, Fukai Y, Tajima K, Masuda N, Tsutsumi S, Tsukada K, Nakajima T, Kuwano H. Kato H, et al. Among authors: miyazaki t. Cancer Lett. 2000 May 29;153(1-2):121-7. doi: 10.1016/s0304-3835(00)00358-x. Cancer Lett. 2000. PMID: 10779640
Anticancer effects of gallic acid isolated from Indonesian herbal medicine, Phaleria macrocarpa (Scheff.) Boerl, on human cancer cell lines.
Faried A, Kurnia D, Faried LS, Usman N, Miyazaki T, Kato H, Kuwano H. Faried A, et al. Among authors: miyazaki t. Int J Oncol. 2007 Mar;30(3):605-13. doi: 10.3892/ijo.30.3.605. Int J Oncol. 2007. PMID: 17273761
Expression of carbonic anhydrase 9, a potential intrinsic marker of hypoxia, is associated with poor prognosis in oesophageal squamous cell carcinoma.
Tanaka N, Kato H, Inose T, Kimura H, Faried A, Sohda M, Nakajima M, Fukai Y, Miyazaki T, Masuda N, Fukuchi M, Kuwano H. Tanaka N, et al. Among authors: miyazaki t. Br J Cancer. 2008 Nov 4;99(9):1468-75. doi: 10.1038/sj.bjc.6604719. Epub 2008 Oct 7. Br J Cancer. 2008. PMID: 18841153 Free PMC article.
Expression of nitrotyrosine is associated with angiogenesis in esophageal squamous cell carcinoma.
Kato H, Miyazaki T, Yoshikawa M, Nakajima M, Fukai Y, Masuda N, Ojima H, Tsukada K, Nishida Y, Kuwano H. Kato H, et al. Among authors: miyazaki t. Anticancer Res. 2001 Sep-Oct;21(5):3323-9. Anticancer Res. 2001. PMID: 11848490
3,608 results
Jump to page
Feedback